Literature DB >> 10658072

Radical resection of periampullary tumors in the elderly: evaluation of long-term results.

O F Bathe1, D Levi, H Caldera, D Franceschi, L Raez, A Patel, W A Raub, P Benedetto, R Reddy, D Hutson, D Sleeman, A S Livingstone, J U Levi.   

Abstract

Increasingly, patients of advanced age are coming for evaluation of periampullary tumors. Although several studies have demonstrated the safety of resecting periampullary tumors in older patients, few long-term survival data have been reported. Between 1983 and 1992 various periampullary masses were resected in 70 patients over age 65 (range 65-87 years). Total pancreatectomy was performed in 11 patients, and 59 patients underwent pancreaticoduodenectomy. The mean duration of hospitalization was 17 +/- 15 days. Major complications occurred in 27 patients (39%), and operative mortality rate was 8.5%. Overall median survival was 24 months; and 5-year survival was 25%. Perioperative outcome was compared in patients aged 65 to 74 years and in patients > or =75 years old. The older age group required longer periods in the surgical intensive care unit postoperatively, but the long-term survival was similar in the two age groups. Radical resection with the intent to cure periampullary tumors is safe in selected patients of advanced age, and long-term survival is in the range of expected survival for younger patients with the same tumors.

Entities:  

Mesh:

Year:  2000        PMID: 10658072     DOI: 10.1007/s002689910056

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  25 in total

Review 1.  Advanced age is a risk factor for post-operative complications and mortality after a pancreaticoduodenectomy: a meta-analysis and systematic review.

Authors:  Prashant Sukharamwala; Sukharamwala Prashant; Jonathan Thoens; Thoens Jonathan; Mauricio Szuchmacher; Szuchmacher Mauricio; James Smith; Smith James; Peter DeVito; DeVito Peter
Journal:  HPB (Oxford)       Date:  2012-06-27       Impact factor: 3.647

2.  Current surgical management of pancreatic cancer.

Authors:  Charles B Kim; Shuja Ahmed; Eddy C Hsueh
Journal:  J Gastrointest Oncol       Date:  2011-09

Review 3.  Should we deny surgery for malignant hepato-pancreatico-biliary tumors to elderly patients?

Authors:  Henrik Petrowsky; Pierre-Alain Clavien
Journal:  World J Surg       Date:  2005-09       Impact factor: 3.352

Review 4.  Current treatment strategies for pancreatic cancer in the elderly.

Authors:  Keiji Hanada; Fumiaki Hino; Hajime Amano; Toshikatsu Fukuda; Yoshinori Kuroda
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

5.  Pancreatic resection in elderly patients: should it be denied?

Authors:  M Adham; L C Bredt; M Robert; J Perinel; C Lombard-Bohas; T Ponchon; P J Valette
Journal:  Langenbecks Arch Surg       Date:  2014-03-27       Impact factor: 3.445

6.  Pancreatic resection in the octogenarian: a safe option for pancreatic malignancy.

Authors:  Ioannis Hatzaras; Carl Schmidt; Dori Klemanski; Peter Muscarella; W Scott Melvin; E Christopher Ellison; Mark Bloomston
Journal:  J Am Coll Surg       Date:  2011-01-12       Impact factor: 6.113

7.  Do not deny pancreatic resection to elderly patients.

Authors:  Roberto Ballarin; Mario Spaggiari; Fabrizio Di Benedetto; Roberto Montalti; Michele Masetti; Nicola De Ruvo; Antonio Romano; Gian Piero Guerrini; Maria Grazia De Blasiis; Giorgio Enrico Gerunda
Journal:  J Gastrointest Surg       Date:  2008-09-11       Impact factor: 3.452

Review 8.  What is the effect of age on pancreatic resection?

Authors:  Taylor S Riall
Journal:  Adv Surg       Date:  2009

9.  The effect of age on short-term outcomes after pancreatic resection: a population-based study.

Authors:  Taylor S Riall; Deepthi M Reddy; William H Nealon; James S Goodwin
Journal:  Ann Surg       Date:  2008-09       Impact factor: 12.969

10.  Preoperative staging and evaluation of resectability in pancreatic ductal adenocarcinoma.

Authors:  R Andersson; C E Vagianos; R C N Williamson
Journal:  HPB (Oxford)       Date:  2004       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.